Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Eye Drops for Dry Eye Disease
NCT05692739Phase 4Completed
- Start
- Oct 2022
- Primary completion
- Nov 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of human insulin in dry eye disease (DED) (3 arms). Primary endpoint: Change of corneal staining at 6 months. Started Oct 2022; status: completed.
02
Drugs
human insulin
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05692739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05692739.